Telomir Pharmaceuticals News

Telomir Pharma: Hugh McColl III, Talhia Tuck and Brad Kroenig Resign From the Board>TELO

Dow Jones5minutes ago

Telomir Pharma Names Matthew P. Del Giudice, Ned MacPherson and Matthew Pratt Whalen to Board >TELO

Dow Jones5minutes ago

Telomir Pharmaceuticals Appoints Erez Aminov as CEO and Chairman of the Bd >TELO

Dow Jones6minutes ago

Press Release: Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman

Dow Jones8minutes ago

Individual Investors Are Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners and Were Rewarded After Market Cap Rose by US$24m Last Week

Yahoo FinanceAug 9 09:13 ET

Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes

GlobeNewswireJul 2 08:30 ET

Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel

GlobeNewswireJun 17 16:10 ET

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1

GlobeNewswireMay 30 08:30 ET

New to The Street TV Announces Episode 575 With Its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ET

GlobeNewswireMay 24 09:30 ET

Telomir Pharmaceuticals, Inc. Signs Media Deal With New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support

GlobeNewswireMay 16 09:30 ET

Telomir Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 13 16:36 ET · Announcements

Telomir Pharmaceuticals Sees Breakthrough Potential in Anti-Aging Treatment With Telomir 1 | NASDAQ:TELO

Proactive InvestorsMay 7 10:52 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

BenzingaApr 30 16:31 ET

MRIN, WISA and SMFL Among Mid-day Movers

Seeking AlphaApr 22 12:52 ET

12 Health Care Stocks Moving In Monday's Intraday Session

BenzingaApr 22 12:31 ET

Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.

GlobeNewswireApr 16 08:30 ET

Telomir Pharmaceuticals Unveils Research Direction at NPC

TipRanksApr 15 16:35 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

BenzingaApr 10 12:31 ET

Telomir Pharmaceuticals' Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024

GlobeNewswireApr 2 08:30 ET

UPDATE – Telomir Pharmaceuticals Announces Collaboration With Argenta to Study Osteoarthritis in Canines

GlobeNewswireMar 29 16:44 ET